Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
First-Line Dual Checkpoint Blockade for NSCLC?
Adding a second checkpoint inhibitor to chemotherapy improves outcomes among patients with non–small cell lung cancer (NSCLC) who have STK11 and/or KEAP1 mutations, according to the authors of a new paper. These findings, drawn from a post hoc analysis of phase…
English